Development of a succinyl CoA:3-ketoacid CoA transferase inhibitor selective for peripheral tissues that improves glycemia in obesity
Seyed Amirhossein Tabatabaei Dakhili(University of Alberta), John R. Ussher(University of Alberta), Kunyan Yang(University of Alberta), Carlos A. Velázquez‐Martínez(University of Alberta), Christina T. Saed(University of Alberta), Rabih Abou Farraj(University of Alberta), Rakesh Bhat(University of Alberta), Cory S. Wagg(University of Alberta), Jenilee Woodfield(University of Alberta), Farah Eaton(University of Alberta), J. N. Mark Glover(University of Alberta), Dion R. Brocks(University of Alberta), Melinda Wuest(University of Alberta), Amanda A. Greenwell(University of Alberta), Jonathan E. Campbell(Duke University), Jordan S. F. Chan(University of Alberta), Frank Wuest(University of Alberta), Indiresh A Mangra-Bala(University of Alberta), Keshav Gopal(University of Alberta), Tanin Shafaati(University of Alberta), Sally R. Ferrari(University of Alberta), Megan E. Capozzi(Duke University), Hamdah Al Nebaihi(University of Alberta), Michael Overduin(University of Birmingham)
Cited by 2
Related Papers
In situ click chemistry generation of cyclooxygenase-2 inhibitors
|Nature Communications|2017|7.5k
Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides
|Nature|1992|689
Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency
|Cardiovascular Research|2019|195
Chronic Inhibition of Pyruvate Dehydrogenase in Heart Triggers an Adaptive Metabolic Response
|Journal of Biological Chemistry|2011|113